Dysregulated Amino Acid Sensing Drives Colorectal Cancer Growth and Metabolic Reprogramming Leading to Chemoresistance
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dysregulated Amino Acid Sensing Drives Colorectal Cancer Growth and Metabolic Reprogramming Leading to Chemoresistance
Authors
Keywords
-
Journal
GASTROENTEROLOGY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2022-11-18
DOI
10.1053/j.gastro.2022.11.014
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2022
- (2022) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Activating mTOR mutations are detrimental in nutrient-poor conditions.
- (2022) Agata A. Bielska et al. CANCER RESEARCH
- Genomic alterations in PIK3CA-mutated breast cancer result in mTORC1 activation and limit sensitivity to PI3Kα inhibitors
- (2021) Yanyan Cai et al. CANCER RESEARCH
- Genetic and biological hallmarks of colorectal cancer
- (2021) Jiexi Li et al. GENES & DEVELOPMENT
- PI3K inhibitors are finally coming of age
- (2021) Bart Vanhaesebroeck et al. NATURE REVIEWS DRUG DISCOVERY
- Reuterin in the healthy gut microbiome suppresses colorectal cancer growth through altering redox balance
- (2021) Hannah N. Bell et al. CANCER CELL
- The GATOR2–mTORC2 axis mediates Sestrin2-induced AKT Ser/Thr kinase activation
- (2020) Allison Ho Kowalsky et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- mTOR at the nexus of nutrition, growth, ageing and disease
- (2020) Grace Y. Liu et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Dietary modifications for enhanced cancer therapy
- (2020) Naama Kanarek et al. NATURE
- Single-Cell Transcriptome Analysis of Colon Cancer Cell Response to 5-Fluorouracil-Induced DNA Damage
- (2020) Sung Rye Park et al. Cell Reports
- Role of mTORC1 in intestinal epithelial repair and tumorigenesis
- (2019) Harleen Kaur et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Temporal induction of intestinal epithelial hypoxia-inducible factor-2α is sufficient to drive colitis
- (2019) Sumeet Solanki et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Nutrient mTORC1 signaling underpins regulatory T cell control of immune tolerance
- (2019) Mytrang H. Do et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Low-Protein Diet Induces IRE1α-Dependent Anticancer Immunosurveillance
- (2018) Camila Rubio-Patiño et al. Cell Metabolism
- Architecture of the human GATOR1 and GATOR1–Rag GTPases complexes
- (2018) Kuang Shen et al. NATURE
- Nutrient and Metabolic Sensing in T Cell Responses
- (2017) Jun Wei et al. Frontiers in Immunology
- Iron Uptake via DMT1 Integrates Cell Cycle with JAK-STAT3 Signaling to Promote Colorectal Tumorigenesis
- (2016) Xiang Xue et al. Cell Metabolism
- Tumor suppressive role of sestrin2 during colitis and colon carcinogenesis
- (2016) Seung-Hyun Ro et al. eLife
- Complications of mammalian target of rapamycin inhibitor anticancer treatment among patients with tuberous sclerosis complex are common and occasionally life-threatening
- (2015) Joanna Trelinska et al. ANTI-CANCER DRUGS
- The Utilization of Extracellular Proteins as Nutrients Is Suppressed by mTORC1
- (2015) Wilhelm Palm et al. CELL
- Restriction of dietary protein decreases mTORC1 in tumors and somatic tissues of a tumor-bearing mouse xenograft model
- (2015) Dudley W. Lamming et al. Oncotarget
- Dietary protein restriction inhibits tumor growth in human xenograft models
- (2015) Luigi Fontana et al. Oncotarget
- mTOR pathway in colorectal cancer: an update
- (2015) Maria Giovanna Francipane et al. Oncotarget
- Spatial Control of the TSC Complex Integrates Insulin and Nutrient Regulation of mTORC1 at the Lysosome
- (2014) Suchithra Menon et al. CELL
- Regulation of mTORC1 by amino acids
- (2014) Liron Bar-Peled et al. TRENDS IN CELL BIOLOGY
- Dysregulated mTORC1 renders cells critically dependent on desaturated lipids for survival under tumor-like stress
- (2013) R. M. Young et al. GENES & DEVELOPMENT
- Tandutinib Inhibits the Akt/mTOR Signaling Pathway to Inhibit Colon Cancer Growth
- (2013) S. Ponnurangam et al. MOLECULAR CANCER THERAPEUTICS
- A Tumor Suppressor Complex with GAP Activity for the Rag GTPases That Signal Amino Acid Sufficiency to mTORC1
- (2013) L. Bar-Peled et al. SCIENCE
- TORC1 Suppression Predicts Responsiveness to RAF and MEK Inhibition in BRAF-Mutant Melanoma
- (2013) R. B. Corcoran et al. Science Translational Medicine
- mTORC1 Inhibition Is Required for Sensitivity to PI3K p110 Inhibitors in PIK3CA-Mutant Breast Cancer
- (2013) M. Elkabets et al. Science Translational Medicine
- Molecular Genetics of Colorectal Cancer
- (2011) Eric R. Fearon Annual Review of Pathology-Mechanisms of Disease
- p53 Target Genes Sestrin1 and Sestrin2 Connect Genotoxic Stress and mTOR Signaling
- (2008) Andrei V. Budanov et al. CELL
- Loss of the Tuberous Sclerosis Complex Tumor Suppressors Triggers the Unfolded Protein Response to Regulate Insulin Signaling and Apoptosis
- (2008) Umut Ozcan et al. MOLECULAR CELL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now